Neoisoliquiritigenin Inhibits Tumor Progression by Targeting GRP78-β- catenin Signaling in Breast Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|18|4|390-399

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.18, Iss.4, 2018-04, pp. : 390-399

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

FOXP2 Promotes Tumor Proliferation and Metastasis by Targeting GRP78 in Triple-negative Breast Cancer

By  

Current Cancer Drug Targets, Vol. 18, Iss. 4, 2018-04 ,pp. : 382-389

Bentham Science Publishers

Access to resources Recommend Favorite

A Wnt-ow of Opportunity: Targeting the Wnt/&bgr;-Catenin Pathway in Breast Cancer

By  

Current Drug Targets, Vol. 11, Iss. 9, 2010-09 ,pp. : 1074-1088

Bentham Science Publishers

Access to resources Recommend Favorite

The potential of targeting Wnt/β-catenin in colon cancer

By Sebio Ana   Kahn Michael   Lenz Heinz-Josef  

Expert Opinion on Therapeutic Targets, Vol. 18, Iss. 6, 2014-06 ,pp. : 611-615

Informa Healthcare

Access to resources Recommend Favorite

PDGF/PDGFR Signaling and Targeting in Cancer Growth and Progression: Focus on Tumor Microenvironment and Cancer-associated Fibroblasts

By  

Current Pharmaceutical Design, Vol. 20, Iss. 17, 2014-05 ,pp. : 2843-2848

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting TGF-β signaling in cancer

By Katz Lior H  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 7, 2013-10 ,pp. : 743-760

Informa Healthcare

Access to resources Recommend Favorite